# Regeneron Pharmaceuticals: what changed between 2025-11-09 and 2026-11-09 entity: /record/regeneron-pharmaceuticals.md from: 2025-11-09 to: 2026-11-09 page: /record/regeneron-pharmaceuticals/diff?from=2025-11-09&to=2026-11-09 json: /v1/entities/regeneron-pharmaceuticals/diff?from=2025-11-09&to=2026-11-09 Between 2025-11-09 and 2026-11-09, Regeneron Pharmaceuticals's record changed in 18 facts: 4 replaced (net income $4.41 billion → $4.5 billion; operating income $3.99 billion → $3.58 billion; research and development $5.13 billion → $5.85 billion and 1 more), 7 added, 7 ended; 11 unchanged. State as of 2025-11-09: /record/regeneron-pharmaceuticals.md?as_of=2025-11-09 · as of 2026-11-09: /record/regeneron-pharmaceuticals.md?as_of=2026-11-09. Format: subject | predicate | value | valid range | confidence | status | claim. Posts and Hugging Face repos are left out (0 held on 2025-11-09, 0 on 2026-11-09). ## Replaced (4) The same fact with a different value: the claim that held on the earlier day, then the one that holds on the later day. - net income: $4.41 billion → $4.5 billion - [Regeneron Pharmaceuticals](/record/regeneron-pharmaceuticals.md) | net_income | 4,412,600,000 United States dollar | valid 2024-12-31 to 2025-12-31 | conf 0.95 | superseded | superseded_by [clm_7514724ED5E9](/claim/clm_7514724ED5E9.md) | [clm_4E27594C511A](/claim/clm_4E27594C511A.md) sources: https://www.sec.gov/Archives/edgar/data/872589/000180422025000011/0001804220-25-000011-index.htm - [Regeneron Pharmaceuticals](/record/regeneron-pharmaceuticals.md) | net_income | 4,504,900,000 United States dollar | valid 2025-12-31 to present | conf 0.95 | valid | [clm_7514724ED5E9](/claim/clm_7514724ED5E9.md) sources: https://www.sec.gov/Archives/edgar/data/872589/000087258926000008/0000872589-26-000008-index.htm - operating income: $3.99 billion → $3.58 billion - [Regeneron Pharmaceuticals](/record/regeneron-pharmaceuticals.md) | operating_income | 3,990,700,000 United States dollar | valid 2024-12-31 to 2025-12-31 | conf 0.95 | superseded | superseded_by [clm_1B456AFB0CC5](/claim/clm_1B456AFB0CC5.md) | [clm_398CD3D76930](/claim/clm_398CD3D76930.md) sources: https://www.sec.gov/Archives/edgar/data/872589/000180422025000011/0001804220-25-000011-index.htm - [Regeneron Pharmaceuticals](/record/regeneron-pharmaceuticals.md) | operating_income | 3,577,900,000 United States dollar | valid 2025-12-31 to present | conf 0.95 | valid | [clm_1B456AFB0CC5](/claim/clm_1B456AFB0CC5.md) sources: https://www.sec.gov/Archives/edgar/data/872589/000087258926000008/0000872589-26-000008-index.htm - research and development: $5.13 billion → $5.85 billion - [Regeneron Pharmaceuticals](/record/regeneron-pharmaceuticals.md) | research_and_development | 5,132,000,000 United States dollar | valid 2024-12-31 to 2025-12-31 | conf 0.95 | superseded | superseded_by [clm_1819F20C7CC4](/claim/clm_1819F20C7CC4.md) | [clm_C301E7CAF361](/claim/clm_C301E7CAF361.md) sources: https://www.sec.gov/Archives/edgar/data/872589/000180422025000011/0001804220-25-000011-index.htm - [Regeneron Pharmaceuticals](/record/regeneron-pharmaceuticals.md) | research_and_development | 5,850,200,000 United States dollar | valid 2025-12-31 to present | conf 0.95 | valid | [clm_1819F20C7CC4](/claim/clm_1819F20C7CC4.md) sources: https://www.sec.gov/Archives/edgar/data/872589/000087258926000008/0000872589-26-000008-index.htm - revenue: $14.2 billion → $14.34 billion - [Regeneron Pharmaceuticals](/record/regeneron-pharmaceuticals.md) | revenue | 14,202,000,000 United States dollar | valid 2024-12-31 to 2025-12-31 | conf 0.95 | superseded | superseded_by [clm_E5421E95D3E6](/claim/clm_E5421E95D3E6.md) | [clm_EE95AAD2339E](/claim/clm_EE95AAD2339E.md) sources: https://www.sec.gov/Archives/edgar/data/872589/000180422025000011/0001804220-25-000011-index.htm - [Regeneron Pharmaceuticals](/record/regeneron-pharmaceuticals.md) | revenue | 14,342,900,000 United States dollar | valid 2025-12-31 to present | conf 0.95 | valid | [clm_E5421E95D3E6](/claim/clm_E5421E95D3E6.md) sources: https://www.sec.gov/Archives/edgar/data/872589/000087258926000008/0000872589-26-000008-index.htm ## Added (7) Held on 2026-11-09, not on 2025-11-09. - [Regeneron Pharmaceuticals](/record/regeneron-pharmaceuticals.md) | cash_and_equivalents | 3,659,100,000 United States dollar | valid 2026-09-30 to present | conf 0.95 | valid | [clm_5EBA4C72A92F](/claim/clm_5EBA4C72A92F.md) sources: https://www.sec.gov/Archives/edgar/data/872589/000087258926000034/0000872589-26-000034-index.htm - [Regeneron Pharmaceuticals](/record/regeneron-pharmaceuticals.md) | quarterly_net_income | 1,948,700,000 United States dollar | valid 2026-09-30 to present | conf 0.95 | valid | [clm_DEF587D6916A](/claim/clm_DEF587D6916A.md) sources: https://www.sec.gov/Archives/edgar/data/872589/000087258926000034/0000872589-26-000034-index.htm - [Regeneron Pharmaceuticals](/record/regeneron-pharmaceuticals.md) | quarterly_operating_income | 2,048,200,000 United States dollar | valid 2026-09-30 to present | conf 0.95 | valid | [clm_4585DB96888D](/claim/clm_4585DB96888D.md) sources: https://www.sec.gov/Archives/edgar/data/872589/000087258926000034/0000872589-26-000034-index.htm - [Regeneron Pharmaceuticals](/record/regeneron-pharmaceuticals.md) | quarterly_research_and_development | 1,794,700,000 United States dollar | valid 2026-09-30 to present | conf 0.95 | valid | [clm_4D8C13296D0A](/claim/clm_4D8C13296D0A.md) sources: https://www.sec.gov/Archives/edgar/data/872589/000087258926000034/0000872589-26-000034-index.htm - [Regeneron Pharmaceuticals](/record/regeneron-pharmaceuticals.md) | quarterly_revenue | 5,115,800,000 United States dollar | valid 2026-09-30 to present | conf 0.95 | valid | [clm_15BDC7B1496E](/claim/clm_15BDC7B1496E.md) sources: https://www.sec.gov/Archives/edgar/data/872589/000087258926000034/0000872589-26-000034-index.htm - [Regeneron Pharmaceuticals](/record/regeneron-pharmaceuticals.md) | total_assets | 44,405,200,000 United States dollar | valid 2026-09-30 to present | conf 0.95 | valid | [clm_F46BE3EF6472](/claim/clm_F46BE3EF6472.md) sources: https://www.sec.gov/Archives/edgar/data/872589/000087258926000034/0000872589-26-000034-index.htm - [Regeneron Pharmaceuticals](/record/regeneron-pharmaceuticals.md) | total_equity | 33,498,500,000 United States dollar | valid 2026-09-30 to present | conf 0.95 | valid | [clm_24A29A7153C0](/claim/clm_24A29A7153C0.md) sources: https://www.sec.gov/Archives/edgar/data/872589/000087258926000034/0000872589-26-000034-index.htm ## Ended (7) Held on 2025-11-09, not on 2026-11-09, and not replaced by another value. - [Regeneron Pharmaceuticals](/record/regeneron-pharmaceuticals.md) | cash_and_equivalents | 2,506,400,000 United States dollar | valid 2025-09-30 to 2025-12-31 | conf 0.95 | superseded | superseded_by [clm_B18C1963BC40](/claim/clm_B18C1963BC40.md) | [clm_5CC511D1F933](/claim/clm_5CC511D1F933.md) sources: https://www.sec.gov/Archives/edgar/data/872589/000087258925000028/0000872589-25-000028-index.htm - [Regeneron Pharmaceuticals](/record/regeneron-pharmaceuticals.md) | quarterly_net_income | 1,460,000,000 United States dollar | valid 2025-09-30 to 2026-03-31 | conf 0.95 | superseded | superseded_by [clm_55728063B1D6](/claim/clm_55728063B1D6.md) | [clm_75B9586D5FEE](/claim/clm_75B9586D5FEE.md) sources: https://www.sec.gov/Archives/edgar/data/872589/000087258925000028/0000872589-25-000028-index.htm - [Regeneron Pharmaceuticals](/record/regeneron-pharmaceuticals.md) | quarterly_operating_income | 1,026,800,000 United States dollar | valid 2025-09-30 to 2026-03-31 | conf 0.95 | superseded | superseded_by [clm_6BF4C3658A74](/claim/clm_6BF4C3658A74.md) | [clm_0F41A2F44A01](/claim/clm_0F41A2F44A01.md) sources: https://www.sec.gov/Archives/edgar/data/872589/000087258925000028/0000872589-25-000028-index.htm - [Regeneron Pharmaceuticals](/record/regeneron-pharmaceuticals.md) | quarterly_research_and_development | 1,475,000,000 United States dollar | valid 2025-09-30 to 2026-03-31 | conf 0.95 | superseded | superseded_by [clm_D76E4D0088C5](/claim/clm_D76E4D0088C5.md) | [clm_F00F9DA4362C](/claim/clm_F00F9DA4362C.md) sources: https://www.sec.gov/Archives/edgar/data/872589/000087258925000028/0000872589-25-000028-index.htm - [Regeneron Pharmaceuticals](/record/regeneron-pharmaceuticals.md) | quarterly_revenue | 3,754,300,000 United States dollar | valid 2025-09-30 to 2026-03-31 | conf 0.95 | superseded | superseded_by [clm_89291214D4AA](/claim/clm_89291214D4AA.md) | [clm_471EC2DBAE0B](/claim/clm_471EC2DBAE0B.md) sources: https://www.sec.gov/Archives/edgar/data/872589/000087258925000028/0000872589-25-000028-index.htm - [Regeneron Pharmaceuticals](/record/regeneron-pharmaceuticals.md) | total_assets | 40,169,400,000 United States dollar | valid 2025-09-30 to 2025-12-31 | conf 0.95 | superseded | superseded_by [clm_CFD74D844717](/claim/clm_CFD74D844717.md) | [clm_A47C41C5A48C](/claim/clm_A47C41C5A48C.md) sources: https://www.sec.gov/Archives/edgar/data/872589/000087258925000028/0000872589-25-000028-index.htm - [Regeneron Pharmaceuticals](/record/regeneron-pharmaceuticals.md) | total_equity | 30,957,800,000 United States dollar | valid 2025-09-30 to 2025-12-31 | conf 0.95 | superseded | superseded_by [clm_68C522C0BDED](/claim/clm_68C522C0BDED.md) | [clm_CF9BA729AF1E](/claim/clm_CF9BA729AF1E.md) sources: https://www.sec.gov/Archives/edgar/data/872589/000087258925000028/0000872589-25-000028-index.htm ## Unchanged 11 claims held on both days: ceo 1, cfo 1, cik 1, fiscal_year_end 1, headquarters 1, listed_on 1, registrant_name 1, shares_outstanding 1, sic_industry 1, state_of_incorporation 1, ticker 1. ## Get this data - JSON: /v1/entities/regeneron-pharmaceuticals/diff?from=2025-11-09&to=2026-11-09 - MCP: entity_diff(entity: "regeneron-pharmaceuticals", from: "2025-11-09", to: "2026-11-09") - Entity twin: /record/regeneron-pharmaceuticals.md · timeline: /timelines/regeneron-pharmaceuticals.md --- AsOf is a temporal fact ledger: a structured, dated, sourced record of what is true and what changed, built for AI retrieval.